[Staphyloimmunocide in the therapy of chronic ulcerative pyoderma].
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D000998:Antiviral Agents / Q000627:therapeutic use*; D002118:Calcium / Q000627:therapeutic use; D002908:Chronic Disease; D004338:Drug Combinations; D005942:Gluconates / Q000627:therapeutic use; D005990:Glycerol / Q000627:therapeutic use; D006801:Humans; D006967:Hypersensitivity / Q000188:drug therapy; D009824:Ointments; D011398:Promethazine / Q000627:therapeutic use; D011711:Pyoderma / Q000188:drug therapy*; D011804:Quinolines / Q000627:therapeutic use*; D012883:Skin Ulcer / Q000188:drug therapy*; D013210:Staphylococcus
D000900:Anti-Bacterial Agents; D000998:Antiviral Agents; D004338:Drug Combinations; D005942:Gluconates; D009824:Ointments; D011804:Quinolines; D011398:Promethazine; D005990:Glycerol; D002118:Calcium
Stafiloimmunotasid v terapii khronicheskoi iazvennoi piodermii.